A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)
Clinical trial NCT00877448 · COMPLETED
Trial details
- NCT number
- NCT00877448
- Sponsor
- BiondVax Pharmaceuticals ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2009-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.